Policy & Regulation

EMA guidance on biosimilar monoclonal antibodies

Read more

An interview with Thomas Lönngren -- Managing change at the EMA

Read more

European Commission lifts funding for innovation

Read more

Critical Path Initiative at the FDA

Read more

Breakthrough for cannabis medicines

Read more

The road to healthcare reform in the US

Read more

Regulators to make more information public

Read more

US healthcare reform: where things stand

Read more

Unwinding the mystery behind TGN1412 -- New preclinical tests for immunology drugs

Read more

EMEA explains new certification scheme

Read more